Digital Therapeutics Market size was valued at USD 4.97 Bn. in 2022 and the total Digital Therapeutics revenue is expected to grow at a CAGR of 26.33% from 2023 to 2029, reaching nearly USD 25.55 Bn.
Digital Therapeutics Market Overview:
Digital Therapeutics Market Segmentation:
With the largest market share in 2022, the Treatment/Care-related Applications segment led the market by application, and it is anticipated to continue to lead at the end of the forecast period. Over the course of the forecast period, the diabetes segment is anticipated to lead the market. In 2022, the CDC estimates that 34.2 million people worldwide had diabetes. One of the things propelling the segment's growth is the increasing prevalence of chronic conditions like diabetes and other ailments. Depending on each patient's specific therapeutic needs, digital therapies can assist medical professionals in examining patients' lifestyles and improving treatment plans.
Over the course of the forecast period, obesity, smoking cessation, and cardiovascular diseases are all expected to grow at significant rates. The market is expanding due to the increasing use of digital therapeutic goods to treat respiratory conditions. These products include Adherium's Hailie, Amiko's Respiro, Propeller from Propeller Health, Cohero Health's Breathe Smart, and Teva's CareTRx. Treatment plans for asthma and COPD may be altered by digital medications. This is due to the fact that when treating respiratory disorders, inadequate medication adherence is a major concern. Solutions for digital therapy can help to effectively resolve this problem.
A changing lifestyle that encourages increased calorie intake and decreased physical activity has been largely blamed for the relatively rapid and significant rise in the prevalence of obesity. Increased consumption of fast food, high-fat diets, and excessive use of drinks sweetened with sugar could all be contributing factors to the ongoing rise in the prevalence of obesity.
Get a Sample PDF of the report at –
@ https://www.maximizemarketresearch.com/request-sample/7003
Digital Therapeutics Market Key Players: The key players are
• Noom(US)
• Livongo Health(US)
• Omada Health(US)
• Virta Health(US)
• Cognoa(US)
• Ayogo Health(US)
• Mindstrong Health(US)
• 2Morrow(US)
• Hinge Health(US)
• BehaVR(US)
• WellDoc(US)
• Pear Therapeutics(US)
• Proteus Digital Health(US)
• Propeller Health(US)
• Akili Interactive Labs(US)
• Better Therapeutics(US)
• Happify(US)
• Kaia Health(US)
• Mango Health(US)
• Click Therapeutics(US)
• Canary Health(US)
• Wellthy Therapeutics(India)
• Ginger( Australia)
• Mindable Health(Germany)
• Doktor.se( Sweden)
Get a Sample PDF of the report at –
@ https://www.maximizemarketresearch.com/market-report/global-digital-therapeutics-market/7003/
Digital Therapeutics Market Regional Analysis:
The Digital Therapeutics market prediction research is created after a thorough examination of many geographical areas, including Asia-Pacific, Europe, North America, and the rest of the globe. North America has the greatest power over the Digital Therapeutics market share and will continue to be a major shareholder in the global Digital Therapeutics market.
COVID-19 Impact Analysis on Digital Therapeutics Market: The COVID-19 impact on the Digital Therapeutics market is also included in the report
Key Questions Answered in the Digital Therapeutics Market Report are:
- What will be the CAGR of the Digital Therapeutics market during the forecast period?
- Which segment emerged as the leading segment in the Digital Therapeutics market?
- Which are the prominent players in the Digital Therapeutics market?
About Us